Compromised Hippocampal Neuroplasticity in the Interferon-α and Toll-like Receptor-3 Activation-Induced Mouse Depression Model

[1]  Brendon O. Watson,et al.  Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test , 2019, PloS one.

[2]  Chiung-Ya Chen,et al.  Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs , 2018, The Journal of cell biology.

[3]  N. Gay,et al.  Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neurons , 2018, Neuropharmacology.

[4]  Guang Yang,et al.  CX3CR1+ monocytes modulate learning and learning-dependent dendritic spine remodeling via TNFα , 2017, Nature Medicine.

[5]  F. Artigas,et al.  Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats , 2017, Translational Psychiatry.

[6]  G. Tejeda,et al.  Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies , 2017, International journal of molecular sciences.

[7]  Chiung-Ya Chen,et al.  TLR3 downregulates expression of schizophrenia gene Disc1 via MYD88 to control neuronal morphology , 2016, EMBO reports.

[8]  T. Arzberger,et al.  Kallikrein-8 Inhibition Attenuates Alzheimer's Pathology in Mice , 2022 .

[9]  U. Meyer,et al.  Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies , 2016, Brain, Behavior, and Immunity.

[10]  M. Hotopf,et al.  Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression , 2016, Neuropsychopharmacology.

[11]  I. Weiner,et al.  Maternal immune activation produces neonatal excitability defects in offspring hippocampal neurons from pregnant rats treated with poly I:C , 2016, Scientific Reports.

[12]  A. Faissner,et al.  Neuron-Glia Interactions in Neural Plasticity: Contributions of Neural Extracellular Matrix and Perineuronal Nets , 2016, Neural plasticity.

[13]  G. Gerken,et al.  Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection , 2015, Molecular Neurobiology.

[14]  W. Tyor,et al.  Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor. , 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  K. Sawamoto,et al.  Minocycline treatment ameliorates interferon-alpha- induced neurogenic defects and depression-like behaviors in mice , 2015, Front. Cell. Neurosci..

[16]  D. Hermann,et al.  Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation , 2014, Brain, Behavior, and Immunity.

[17]  S. Kanba,et al.  Mechanisms for Interferon-α-Induced Depression and Neural Stem Cell Dysfunction , 2014, Stem cell reports.

[18]  Chiung-Ya Chen,et al.  Sarm1 deficiency impairs synaptic function and leads to behavioral deficits, which can be ameliorated by an mGluR allosteric modulator , 2014, Front. Cell. Neurosci..

[19]  D. Sobieraj,et al.  Prevention of interferon‐alpha‐associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta‐analysis , 2014, International journal of clinical practice.

[20]  G. Gerken,et al.  Concomitant Interferon Alpha Stimulation and TLR3 Activation Induces Neuronal Expression of Depression-Related Genes That Are Elevated in the Brain of Suicidal Persons , 2013, PloS one.

[21]  T. Jay,et al.  The hippocampal–prefrontal pathway: The weak link in psychiatric disorders? , 2013, European Neuropsychopharmacology.

[22]  M. Lynch,et al.  Toll‐like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon‐β , 2013, Hippocampus.

[23]  P. Cowen,et al.  Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study , 2013, Psychological Medicine.

[24]  T. Connor,et al.  Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression , 2013, Brain, Behavior, and Immunity.

[25]  D. Schmitz,et al.  Compromised fidelity of endocytic synaptic vesicle protein sorting in the absence of stonin 2 , 2013, Proceedings of the National Academy of Sciences.

[26]  M. Olianas,et al.  Type I interferons impair BDNF‐induced cell signaling and neurotrophic activity in differentiated human SH‐SY5Y neuroblastoma cells and mouse primary cortical neurons , 2012, Journal of neurochemistry.

[27]  Robert A. Smith,et al.  Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring , 2012, Molecular Brain.

[28]  M. Cynader,et al.  Opposing Roles of Synaptic and Extrasynaptic NMDA Receptor Signaling in Cocultured Striatal and Cortical Neurons , 2012, Journal of Neuroscience.

[29]  G. Sanacora,et al.  Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders , 2012, Neuropharmacology.

[30]  S. Traynelis,et al.  PKC phosphorylates GluA1-Ser831 to enhance AMPA receptor conductance , 2012, Channels.

[31]  Kristina D. Micheva,et al.  Classical MHCI Molecules Regulate Retinogeniculate Refinement and Limit Ocular Dominance Plasticity , 2009, Neuron.

[32]  M. Esiri,et al.  Down‐regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease , 2006, Journal of neurochemistry.

[33]  P. Scumpia,et al.  Double‐stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3‐expressing astrocytes , 2005, Glia.

[34]  D. Copenhagen,et al.  Vesicular Glutamate Transporters 1 and 2 Target to Functionally Distinct Synaptic Release Sites , 2004, Science.

[35]  A. Heinz,et al.  Neurotransmitter changes by interferon-alpha and therapeutic implications. , 2003, Pharmacopsychiatry.

[36]  R. Andrew,et al.  Interferon-α inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus , 2000, Brain Research.

[37]  Shuxian Hu,et al.  Cytokine Effects on Glutamate Uptake by Human Astrocytes , 2000, Neuroimmunomodulation.

[38]  H. Steinbusch,et al.  Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor? , 2011, The international journal of neuropsychopharmacology.

[39]  E. Nestler,et al.  Animal models of depression: molecular perspectives. , 2011, Current topics in behavioral neurosciences.